ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY

ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY

We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade. Spontaneously hypertensive rats, 8 weeks old, were treated with olmesartan,...

Full description

Bibliographic Details
Main Authors:	H. Yokoyama, D. B. Averill, K. B. Brosnihan, R. D. Smith, E. L. Schiffrin, C. M. Ferrario
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-08-01
Series:	Российский кардиологический журнал
Subjects:	atenolol cardiac hypertrophy hypertension olmesartan vascular remodelling
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1131

Similar Items

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study
by: Kl. O. Stumpe, et al.
Published: (1970-01-01)

Dietary supplementation of 25-hydroxycholecalciferol improves cardiac function and livability in broiler breeder hens–amelioration of blood pressure and vascular remodeling
by: Yo-Lin Yeh, et al.
Published: (2020-07-01)

Subclinical Target Organ Damage in a Sample of Children with Autosomal Dominant Polycystic Kidney Disease: A Pilot Study
by: Simone Romano, et al.
Published: (2023-10-01)

Psychosomatic status and myocardial hypertrophy remodelling specificity
by: G. A. Usenko, et al.
Published: (2018-12-01)

Transient Receptor Potential Canonical 5 (TRPC5): Regulation of Heart Rate and Protection against Pathological Cardiac Hypertrophy
by: Pratish Thakore, et al.
Published: (2024-04-01)

Cardiac hypertrophy with obesity is augmented after pregnancy in C57BL/6 mice
by: Chen Che, et al.
Published: (2019-12-01)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
by: Youchen Yan, et al.
Published: (2022-03-01)

Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy
by: Jie Li, et al.
Published: (2019-02-01)

Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis
by: Hassan N. Althurwi, et al.
Published: (2020-04-01)

Macrophage depletion protects against endothelial dysfunction and cardiac remodeling in angiotensin II hypertensive mice
by: Yuantong Tian, et al.
Published: (2021-11-01)

Olmesartan/amlodipine: a review of its use in the management of hypertension
by: Kreutz R
Published: (2011-03-01)

Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension
by: Vivek V. Bhosale, et al.
Published: (2014-06-01)

GCIP attenuates DOCA/salt-induced cardiac hypertrophy and fibrosis in mice
by: TANG Kecheng, et al.
Published: (2022-03-01)

Arteriovenous fistula-induced cardiac remodeling shows cardioprotective features in mice
by: Shin-Rong Lee, MD, PhD, et al.
Published: (2021-01-01)

WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: Results of an open label, non-comparative, multi-centric, post marketing observational study
by: D.K. Kumbla, et al.
Published: (2014-05-01)

Galanin promotes autophagy and alleviates apoptosis in the hypertrophied heart through FoxO1 pathway
by: Ilenia Martinelli, et al.
Published: (2021-04-01)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
by: Joana Silva, et al.
Published: (2022-05-01)

The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro
by: Yue Cai, et al.
Published: (2024-08-01)

Casein Kinase-2 Interacting Protein-1 Regulates Physiological Cardiac Hypertrophy via Inhibition of Histone Deacetylase 4 Phosphorylation
by: Yinlong Zhao, et al.
Published: (2021-06-01)

Roles of rutin in cardiac remodeling
by: Hawa Nordin Siti, et al.
Published: (2020-01-01)

Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
by: Sarah-Eve Lemay, et al.
Published: (2021-06-01)

Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes
by: Matsui Hiroki, et al.
Published: (2012-12-01)

Cardiac-Specific PID1 Overexpression Enhances Pressure Overload-Induced Cardiac Hypertrophy in Mice
by: Yaoqiu Liu, et al.
Published: (2015-03-01)

Regulation of cardiac remodeling by cardiac Na/K-ATPase isoforms
by: Lijun Catherine Liu, et al.
Published: (2016-09-01)

Induction of Proteasome Subunit Low Molecular Weight Protein (LMP)-2 Is Required to Induce Active Remodeling in Adult Rat Ventricular Cardiomyocytes
by: Antonia Petersen, et al.
Published: (2020-05-01)

Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice
by: Qing Liang, et al.
Published: (2022-07-01)

Relationship between atenolol and early development of heart failure in hypertensive patients
by: Enaam Ahmad Amin, et al.
Published: (2009-06-01)

The Role of Extracellular Signal-Regulated Kinase Pathways in Different Models of Cardiac Hypertrophy in Rats
by: Gassan Moady, et al.
Published: (2023-08-01)

Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension
by: Richard Mprah, et al.
Published: (2021-04-01)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
by: Ming-Yun Ho, et al.
Published: (2021-08-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats
by: Jie Li, et al.
Published: (2020-04-01)

Severe renal vascular hypertension caused by upper left branch renal artery stenosis complicated with multiple thrombosis and cardiac hypertrophy
by: Milošević Danko, et al.
Published: (2014-06-01)

A time-series minimally invasive transverse aortic constriction mouse model for pressure overload-induced cardiac remodeling and heart failure
by: Xia Wang, et al.
Published: (2023-02-01)

Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy
by: Xiaomei Wang, et al.
Published: (2023-12-01)

Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice
by: Hae Jin Kee, et al.
Published: (2019-06-01)

<i>Parkia speciosa</i> Hassk. Empty Pod Extract Prevents Cardiomyocyte Hypertrophy by Inhibiting MAPK and Calcineurin-NFATC3 Signaling Pathways
by: Nor Hidayah Mustafa, et al.
Published: (2022-12-01)

A Comparative Study of the Effects of Atenolol, Enalapril and Hydrochlorothiazide on Stage II Hypertension
by: Behzad Babapour, et al.
Published: (2013-09-01)

Up-to-Date Aspects of Antihypertensive Therapy from the Viewpoint of Cardioand Nephroprotective Action: Olmesartan
by: A. G. Evdokimova, et al.
Published: (2020-05-01)